493 related articles for article (PubMed ID: 16567005)
1. Evaluation of a new automated assay for hepatitis B surface antigen (HBsAg) detection VIDAS HBsAg Ultra.
Weber B; Van der Taelem-Brulé N; Berger A; Simon F; Geudin M; Ritter J
J Virol Methods; 2006 Jul; 135(1):109-17. PubMed ID: 16567005
[TBL] [Abstract][Full Text] [Related]
2. Multi-center evaluation of the hepatitis B surface antigen (HBsAg) assay and HbsAg confirmatory assay for the family of Access immunoassay systems.
Lunel-Fabiani F; Duburcq X; Levayer T; Descamps F; Maniez-Montreuil M; Pivert A; Ducancelle A; Pouzet A; Marant L; Clèment A; Duhamel D; Leirens Y; Margotteau F; Falcou-Briatte R; Heinen C; Bouniort F; Taskar S; Artus A; Woodrum D; Flecheux O
Clin Lab; 2010; 56(7-8):281-90. PubMed ID: 20857892
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of the VIDAS HIV DUO Ultra assay for combined detection of HIV-1 antigen and antibodies to HIV.
Bourlet T; Pretis C; Pillet S; Lesenechal M; Piche J; Pozzetto B
J Virol Methods; 2005 Aug; 127(2):165-7. PubMed ID: 15967238
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of sensitivity for wild type and mutant forms of hepatitis B surface antigen by four commercial HBsAg assays.
Moerman B; Moons V; Sommer H; Schmitt Y; Stetter M
Clin Lab; 2004; 50(3-4):159-62. PubMed ID: 15074469
[TBL] [Abstract][Full Text] [Related]
5. Improved detection of natural hepatitis B virus surface antigen (HBsAg) mutants by a new version of the VITROS HBsAg assay.
Echevarría JM; Avellón A
J Med Virol; 2008 Apr; 80(4):598-602. PubMed ID: 18297712
[TBL] [Abstract][Full Text] [Related]
6. Performance of hepatitis B assays on the Bayer ADVIA Centaur Immunoassay System.
van Helden J; Denoyel G; Karwowska S; Reamer R; Schmalz J; Wright T; Preisel-Simmons B
Clin Lab; 2004; 50(1-2):63-73. PubMed ID: 15000222
[TBL] [Abstract][Full Text] [Related]
7. The analytic sensitivity and mutant detection capability of six hepatitis B surface antigen assays.
La'ulu SL; Roberts WL
Am J Clin Pathol; 2006 May; 125(5):748-51. PubMed ID: 16707377
[TBL] [Abstract][Full Text] [Related]
8. Early detection of hepatitis B surface antigen--prototype of a new fully automated HBsAg microparticle enzyme immunoassay (MEIA).
Pfeifer K; Pelzer C; Coleman P; Pope M; Kapprell HP
Clin Lab; 2003; 49(3-4):161-6. PubMed ID: 12705699
[TBL] [Abstract][Full Text] [Related]
9. Detection of antibodies to hepatitis B core antigen using the Abbott ARCHITECT anti-HBc assay: analysis of borderline reactive sera.
Ollier L; Laffont C; Kechkekian A; Doglio A; Giordanengo V
J Virol Methods; 2008 Dec; 154(1-2):206-9. PubMed ID: 18848582
[TBL] [Abstract][Full Text] [Related]
10. Lengths of hepatitis B viremia and antigenemia in blood donors: preliminary evidence of occult (hepatitis B surface antigen-negative) infection in the acute stage.
Yoshikawa A; Gotanda Y; Minegishi K; Taira R; Hino S; Tadokoro K; Ohnuma H; Miyakawa K; Tachibana K; Mizoguchi H;
Transfusion; 2007 Jul; 47(7):1162-71. PubMed ID: 17581150
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus markers in anti-HBc only positive individuals.
Weber B; Melchior W; Gehrke R; Doerr HW; Berger A; Rabenau H
J Med Virol; 2001 Jul; 64(3):312-9. PubMed ID: 11424120
[TBL] [Abstract][Full Text] [Related]
12. Sensitivities of four new commercial hepatitis B virus surface antigen (HBsAg) assays in detection of HBsAg mutant forms.
Ly TD; Servant-Delmas A; Bagot S; Gonzalo S; Férey MP; Ebel A; Dussaix E; Laperche S; Roque-Afonso AM
J Clin Microbiol; 2006 Jul; 44(7):2321-6. PubMed ID: 16825343
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of 17 CE-marked HBsAg assays with respect to clinical sensitivity, analytical sensitivity, and hepatitis B virus mutant detection.
Scheiblauer H; Soboll H; Nick S
J Med Virol; 2006; 78 Suppl 1():S66-70. PubMed ID: 16622881
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the technical and clinical performance of the Elecsys HBsAg II assay with the Architect, AxSym, and Advia Centaur HBsAg screening assays.
Louisirirotchanakul S; Khupulsup K; Akraekthalin S; Chan KP; Saw S; Aw TC; Cho DH; Shin MG; Lim J
J Med Virol; 2010 May; 82(5):755-62. PubMed ID: 20336717
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a novel chemiluminescent microplate enzyme immunoassay for hepatitis B surface antigen detection.
Yang L; Song LW; Fang LL; Wu Y; Ge SX; Li H; Yuan Q; Zhang J; Xia NS
J Virol Methods; 2016 Feb; 228():55-9. PubMed ID: 26615806
[TBL] [Abstract][Full Text] [Related]
16. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen.
Katz L; Strong DM; Tegtmeier G; Stramer S
Transfusion; 2008 Nov; 48(11):2315-22. PubMed ID: 18647367
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic impact of the genetic variability of the hepatitis B virus surface antigen gene.
Weber B
J Med Virol; 2006; 78 Suppl 1():S59-65. PubMed ID: 16622880
[TBL] [Abstract][Full Text] [Related]
18. Performance characteristics of an improved version of the ABBOTT IMx HBsAg (V2) MEIA.
Pfeifer K; Dobson C; Herron A; Kapprell HP
Clin Lab; 2002; 48(7-8):359-64. PubMed ID: 12146568
[TBL] [Abstract][Full Text] [Related]
19. A novel hepatitis B virus surface antigen immunoassay as sensitive as hepatitis B virus nucleic acid testing in detecting early infection.
Matsubara N; Kusano O; Sugamata Y; Itoh T; Mizuii M; Tanaka J; Yoshizawa H
Transfusion; 2009 Mar; 49(3):585-95. PubMed ID: 19192255
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of two new automated assays for hepatitis B virus surface antigen (HBsAg) detection: IMMULITE HBsAg and IMMULITE 2000 HBsAg.
Weber B; Dengler T; Berger A; Doerr HW; Rabenau H
J Clin Microbiol; 2003 Jan; 41(1):135-43. PubMed ID: 12517838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
